Skip to content
TriangleGet started
← Back to this collection

PUBLICATIONS · 32731259

A randomized phase 3 trial of zanubrutinib vs ibrutinib in symptomatic Waldenström macroglobulinemia: the ASPEN study.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Blood
Publication date
2020 Oct 29
First author
Tam CS

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Tam CS
      type
      Author
    2. name
      Opat S
      type
      Author
    3. name
      D'Sa S
      type
      Author
    4. name
      Jurczak W
      type
      Author
    5. name
      Lee HP
      type
      Author
    6. name
      Cull G
      type
      Author
    7. name
      Owen RG
      type
      Author
    8. name
      Marlton P
      type
      Author
    9. name
      Wahlin BE
      type
      Author
    10. name
      Sanz RG
      type
      Author
    11. name
      McCarthy H
      type
      Author
    12. name
      Mulligan S
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Tam CS
      type
      Author
    2. name
      Opat S
      type
      Author
    3. name
      D'Sa S
      type
      Author
    4. name
      Jurczak W
      type
      Author
    5. name
      Lee HP
      type
      Author
    6. name
      Cull G
      type
      Author
    7. name
      Owen RG
      type
      Author
    8. name
      Marlton P
      type
      Author
    9. name
      Wahlin BE
      type
      Author
    10. name
      Sanz RG
      type
      Author
    11. name
      McCarthy H
      type
      Author
    12. name
      Mulligan S
      type
      Author
    bibliography ids
    1. nci-bib-4313c0da27ca31a1c75ba2a4
    book metadata
    content sha256
    ecc201b4d3ff8e601a594eda96d1608efe6310a198c08441dd960264d727a1a0
    document type
    citation
    dois
    1. 10.1182/blood.2020006844
    electronic publication date
    display
    Source null
    precision
    missing
    year
    Source null
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:32731259
    immutable id
    pubmed:32731259@ecc201b4d3ff8e601a594eda96d1608efe6310a198c08441dd960264d727a1a0
    journal
    abbreviation
    Blood
    issn electronic
    1528-0020
    issn print
    0006-4971
    issue
    18
    name
    Blood
    nlm unique id
    7603509
    pages
    2038-2050
    volume
    136
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      32731259
      provenance
      batch id
      40d9eae1f1d369f13109
      provider
      NCBI PubMed ESummary
      record sha256
      d5dec42b74cc63b50c86fbf4f8b10c98b82e77e881b4120f8405a49a1e75a92f
      response sha256
      03fa1567b6babd78281d8ec4529596b9d4953c2c4ac23257dca371d609645ba9
      retrieved at
      2026-09-09T23:47:52.637547+00:00
      publication date
      display
      2020 Oct 29
      precision
      day
      year
      2020
      publication types
      1. Clinical Trial, Phase III
      2. Journal Article
      3. Multicenter Study
      4. Randomized Controlled Trial
      5. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/32731259/
      title
      A randomized phase 3 trial of zanubrutinib vs ibrutinib in symptomatic Waldenström macroglobulinemia: the ASPEN study.

      Preserved source evidence · Independent clinical review pending · Not medical advice